NO178682C - Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer - Google Patents

Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer

Info

Publication number
NO178682C
NO178682C NO893637A NO893637A NO178682C NO 178682 C NO178682 C NO 178682C NO 893637 A NO893637 A NO 893637A NO 893637 A NO893637 A NO 893637A NO 178682 C NO178682 C NO 178682C
Authority
NO
Norway
Prior art keywords
blood coagulation
coagulation factors
reagents
well
biological activity
Prior art date
Application number
NO893637A
Other languages
English (en)
Norwegian (no)
Other versions
NO893637L (no
NO178682B (no
NO893637D0 (no
Inventor
Masayasu Enomoto
Original Assignee
Nippon Shoji Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shoji Kk filed Critical Nippon Shoji Kk
Publication of NO893637D0 publication Critical patent/NO893637D0/no
Publication of NO893637L publication Critical patent/NO893637L/no
Publication of NO178682B publication Critical patent/NO178682B/no
Publication of NO178682C publication Critical patent/NO178682C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO893637A 1988-09-12 1989-09-11 Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer NO178682C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63227940A JPH0650999B2 (ja) 1988-09-12 1988-09-12 血液凝固因子安定化法

Publications (4)

Publication Number Publication Date
NO893637D0 NO893637D0 (no) 1989-09-11
NO893637L NO893637L (no) 1990-03-13
NO178682B NO178682B (no) 1996-02-05
NO178682C true NO178682C (no) 1996-05-15

Family

ID=16868667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893637A NO178682C (no) 1988-09-12 1989-09-11 Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer

Country Status (8)

Country Link
US (1) US5147803A (sv)
EP (1) EP0359201B1 (sv)
JP (1) JPH0650999B2 (sv)
DE (1) DE68905117T2 (sv)
DK (1) DK447489A (sv)
ES (1) ES2053897T3 (sv)
FI (1) FI93494C (sv)
NO (1) NO178682C (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650999B2 (ja) * 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法
CA2080428C (en) * 1991-10-22 2004-01-27 Ray F. Ebert A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test
JPH08224227A (ja) * 1995-02-22 1996-09-03 Internatl Reagents Corp 血液採血管
WO1997033178A1 (de) * 1996-03-08 1997-09-12 Octapharma Ag Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
DE19858278A1 (de) * 1998-12-17 2000-06-21 Dade Behring Marburg Gmbh Verfahren zum Lokalisieren von Defekten im Gerinnungssystem
WO2001007921A2 (en) * 1999-07-23 2001-02-01 Medical Analysis Systems, Inc. Stabilized coagulation control reagent
EP1210361B1 (en) * 1999-08-17 2004-04-14 Novo Nordisk Health Care AG Stabilisation of freeze-dried cake
US6586574B1 (en) 1999-08-17 2003-07-01 Nn A/S Stabilization of freeze-dried cake
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6465202B1 (en) * 2000-02-17 2002-10-15 Biosafe Laboratories, Inc. Method for stabilizing aminotransferase activity in a biological fluid
GB0305133D0 (en) * 2003-03-06 2003-04-09 Sinvent As Product
EP2405275B1 (en) 2009-03-05 2018-10-10 BML, Inc. Method for measuring glycated albumin contained in serum or plasma using mannitol as stabiliser for a control serum or plasma.
JP5640189B2 (ja) 2011-06-17 2014-12-17 学校法人東日本学園 ループスアンチコアグラント検出用血液凝固時間の測定方法
WO2012173259A1 (ja) 2011-06-17 2012-12-20 学校法人東日本学園・北海道医療大学 ループスアンチコアグラントの検出方法
JP6116231B2 (ja) * 2012-12-25 2017-04-19 株式会社Lsiメディエンス 組織トロンボプラスチン含有血液凝固能測定試薬及び測定方法
CN106572650B (zh) 2014-06-10 2021-08-31 生物马特里卡公司 在环境温度下稳定凝血细胞
EP3698629A1 (en) * 2014-06-10 2020-08-26 Biomatrica, INC. Stabilization of metabolically-active cells in a blood sample at ambient temperatures
CN104181313B (zh) * 2014-09-04 2015-11-18 中国医学科学院输血研究所 凝血因子ⅸ质控品制备方法
CN105353141B (zh) * 2015-11-17 2018-04-10 北京美创新跃医疗器械有限公司 检测试剂及其应用及含有该试剂的试剂盒
KR20230145258A (ko) 2015-12-08 2023-10-17 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー 凍結乾燥方法
CA3130700A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
JP7473281B1 (ja) * 2022-10-14 2024-04-23 積水メディカル株式会社 凝固第viii、ix又はxi因子欠乏血液検体の血液凝固時間調節剤、及び活性化部分トロンボプラスチン時間測定のための試薬
JP7473282B1 (ja) * 2022-10-14 2024-04-23 積水メディカル株式会社 凝固第xii因子欠乏血液検体の血液凝固時間短縮剤
JP7473283B1 (ja) * 2022-10-14 2024-04-23 積水メディカル株式会社 活性化部分トロンボプラスチン時間測定のための試薬、及びループスアンチコアグラント陽性血液検体又はヘパリン含有血液検体の血液凝固時間調節剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL275394A (sv) * 1961-02-28
US3323995A (en) * 1963-05-20 1967-06-06 Univ Northwestern Method of inhibiting the crosslinking of fibrin in blood
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
US4271122A (en) * 1978-04-27 1981-06-02 Hoffmann-La Roche Inc. Control plasma
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPS57112367A (en) * 1980-12-29 1982-07-13 Sankyo Co Ltd Preparation of stable aqueous solution of compound having thiol group
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第8因子の加熱処理法
JPS59192961A (ja) * 1983-04-15 1984-11-01 Green Cross Corp:The 血液凝固第「じ」因子測定用試薬
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
JPH0650999B2 (ja) * 1988-09-12 1994-07-06 日本商事株式会社 血液凝固因子安定化法

Also Published As

Publication number Publication date
EP0359201A2 (en) 1990-03-21
JPH0650999B2 (ja) 1994-07-06
EP0359201B1 (en) 1993-03-03
JPH0275953A (ja) 1990-03-15
EP0359201A3 (en) 1991-01-09
FI93494C (sv) 1995-04-10
DK447489A (da) 1990-03-13
US5147803A (en) 1992-09-15
FI93494B (sv) 1994-12-30
NO893637L (no) 1990-03-13
FI894303A0 (sv) 1989-09-12
ES2053897T3 (es) 1994-08-01
DE68905117D1 (de) 1993-04-08
FI894303A (sv) 1990-03-13
DK447489D0 (da) 1989-09-11
NO178682B (no) 1996-02-05
NO893637D0 (no) 1989-09-11
DE68905117T2 (de) 1993-08-05

Similar Documents

Publication Publication Date Title
NO178682C (no) Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer
DK427485A (da) Blodkoagulationshaemmende proteiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DE68926385D1 (de) Methode und Hardware-Ausführung von komplexen Datentransferbefehlen
KR900702053A (ko) 동일계 하이브리드화 분석방법
AU5350290A (en) Factor sensitive reagent for testing of blood coagulation
DE68903884D1 (de) Mittel und methode zur bestimmung von spurenmengen an proteinen.
ATE76508T1 (de) Vorrichtung zur feststellung von okkultem blut.
CA1267497C (en) PROTEIN RECOVERY
DE3779706D1 (de) Enzymsensor zur bestimmung von glutaminat-konzentration.
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
DE68917324D1 (de) Methode zur Immobilisierung von physiologisch aktiven Substanzen.
DE68918083D1 (de) Verfahren zur reinigung von blutplasma.
ATE109983T1 (de) Gelkörper und verfahren für biologische sterilisierungssteuerung.
DE3475965D1 (en) Reagent and kit for determination of blood coagulation factor xiii
DE68922550D1 (de) Alkohol-oxidase Enzymelektrode und Verfahren zur Bestimmung von Alkoholeinhalt.
NO864301D0 (no) Dna-prober for human regulatorisk enhet av camp-avhengige proteinkinaser.
PT89138A (pt) Metodo de determinacao de concentracoes de colesterol total em amostras de sangue capilar
AU4484593A (en) Method for the determination of lupus anticoagulant antibodies that cause thrombosis
NZ222332A (en) Enzyme-electrode sensor with outermost layer of its membrane treated with protein denaturing reagent
IT8622049A0 (it) Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti.
ES8704268A1 (es) Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.
NO175434C (no) Rekombinant DNA-vektor, pattedyrcelle transformert med denne samt fremgangsmåte for fremstilling av human plasminogenaktivator
SU1668950A1 (ru) Способ определени активности калпаинов в биологическом материале
AU7692987A (en) Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein)
DE58902472D1 (de) Verfahren und test-kit zur semiquantitativen bestimmung des kalziumgehaltes im blut.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2001